We may acknowledge just how essential the nomadic healthcare workforce has been in efforts to control the Covid-19 pandemic, but what’s often overlooked is how and where these workers are being…
This is the time to embrace radical empathy, profound change, and bold ideas. While the pandemic may have put us all on an unexpected path, there is no turning back from here.
After 19 years at the helm of Alnylam, John Maraganore, Ph.D., is not wasting any time getting started on the next phase of his career.
MedCity Influencers We may acknowledge just how essential the nomadic healthcare workforce has been in efforts to control the Covid-19 pandemic, but what’s often overlooked is how and where these workers are being housed. https://medcitynews.com/author/cabisambra
MedCity Influencers, Opinion Making EHRs more like a butler by serving the needs of clinicians By David Lareau Healthcare leaders can continue to wait for the government to enact and enforce IT changes that may or may not serve the needs of clinicians. Or, they can embrace proven solutions today that make their EHRs a …
A Sanofi strategy shift is leading to the end of a gene-editing alliance with Sangamo Therapeutics. Though the partnership has produced encouraging early clinical data with a sickle cell therapy…
Biotech startup Ambagon Therapeutics is taking a new approach to making elusive protein targets ‘druggable’ by using molecular glues. The biotech has a pipeline of preclinical cancer drugs and it has…
One reason clinicians struggle to find what they need in EHRs is because most legacy systems were not designed to provide a diagnostically holistic view for specific clinical conditions.
There is a palpable shift underway as government leaders and others are adopting a mindset about obesity that is informed by science rather than by prejudice.
After eight years as CEO of Blueprint Medicines, Jeff Albers will become executive chairman in April, current Chief Operating Officer Kate Haviland will become CEO, and Christina Rossi will take on…
